Gene · 26121
Papers3,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial ribosomal proteins: potential targets for cancer prognosis and therapy. | Front Oncol | 2025 | 40371222 | PubTator, text mining | PubMed |
| Targeting long non-coding RNA RP11-502I4.3 inhibits the trend of angiogenesis in diabetic retinopathy. | PLoS One | 2025 | 40367061 | PubTator, text mining | PubMed |
| Identification of Shared Genetic Loci Associated With Inflammatory Bowel Disease, Ischemic Heart Disease, and Atrial Fibrillation and Flutter. | Clin Genet | 2025 | 40343385 | PubTator, text mining | PubMed |
| [Study on Differential DNA Methylation Profiles of Patients with High-Altitude Polycythemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40326138 | PubTator, text mining | PubMed |
| Causal association of immune-related genes with mouth ulcers: findings from summary-based Mendelian randomization and transcriptome-wide association analysis. | Immunol Med | 2025 | 40323146 | PubTator, text mining | PubMed |
| Identification of a cuproptosis‑related prognostic biomarker and therapeutic target in ovarian cancer. | Oncol Lett | 2025 | 40291472 | PubTator, text mining | PubMed |
| Exploring copy number variations in Lebanese families with rod-cone dystrophy reveals a novel deletion in PRPF31 with haploinsufficiency. | Ophthalmic Genet | 2025 | 40289750 | PubTator, text mining | PubMed |
| The RNA content of extracellular vesicles from gene-edited PRPF31 +/- hiPSC-RPE show potential as biomarkers of retinal degeneration. | Mol Ther Methods Clin Dev | 2025 | 40231248 | PubTator, text mining | PubMed |
| Generation of the induced pluripotent stem cell line LEIi023-A from a rod-cone dystrophy patient carrying the dominant PRPF31 c.267del variant. | Stem Cell Res | 2025 | 40220513 | PubTator, text mining | PubMed |
| Identification of mitochondrial permeability transition-related lncRNAs as quantitative biomarkers for the prognosis and therapy of breast cancer. | Front Genet | 2025 | 40206506 | PubTator, text mining | PubMed |
| Exploring organoid and assembloid technologies: a focus on retina and brain. | Expert Rev Mol Med | 2025 | 40145178 | PubTator, text mining | PubMed |
| Unveiling the Genetic and Phenotypic Landscape of a Chinese Cohort With Retinitis Pigmentosa. | Mol Genet Genomic Med | 2025 | 39988772 | PubTator, text mining | PubMed |
| mRNA Transcript Variants Expressed in Mammalian Cells. | Int J Mol Sci | 2025 | 39940824 | PubTator, text mining | PubMed |
| De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa. | medRxiv | 2025 | 39830270 | PubTator, text mining | PubMed |
| Generation of the human iPSC line ESi132-A from a patient with retinitis pigmentosa caused by a mutation in the PRPF31 gene. | Stem Cell Res | 2025 | 39755010 | PubTator, text mining | PubMed |
| Multiancestry Genome-Wide Association Study of Early Childhood Caries. | J Dent Res | 2025 | 39698793 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Integrated Transcriptome Analysis of lncRNA, miRNA, and mRNA Reveals key Regulatory Modules for Polycystic Ovary Syndrome. | Phenomics | 2024 | 40061822 | PubTator, text mining | PubMed |
| Genetic Analysis of Intraductal Carcinoma of the Prostate Detected in High-Grade Prostatic Intraepithelial Neoplasia Cases. | Cureus | 2024 | 39840193 | PubTator, text mining | PubMed |
| An Unusual Case of Overlapping Immunoglobulin G4-Related Disease and Systemic Lupus Erythematosus. | Cureus | 2024 | 39781129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26121/papers?page=6